A unique feature of the insulin receptor is that it is dimeric in the absence of ligand. Dimerization of two adjacent transmembrane domain (TMD) ␣ helices has been shown to be critical in receptor kinase activation. Moreover, previous work has suggested that the TMD is involved in stabilizing the high-affinity binding site; soluble receptors expressed after simple truncation at the ectodomain-TMD junction have reduced affinity for insulin. To further examine this issue, we have replaced the TMD and intracellular domain of the soluble human insulin receptor (HIRs) with constant domains from immunoglobulin Fc and subunits (HIRs-Fc and HIRs-). Studies of receptor biosynthesis and binding characteristics were performed following transient transfection of receptor cDNAs into human embryonal kidney 293 cells. Each hybrid receptor was initially synthesized as a single chain proreceptor, followed by cleavage into ␣-and ␤-Fc or ␤-subunits. The majority of secreted protein appeared in the cell medium as fully processed heterotetramer. Fc fragments released from HIRs-Fc by papain digestion and analyzed by nonreducing SDSpolyacrylamide gel electrophoresis were dimeric. Furthermore, dissociation constants for both chimeras were similar to those for the full-length holoreceptor (wild-type receptor, K d1 ‫؍‬ 200 pM and K d2 ‫؍‬ 2 nM; HIRsFc, K d1 ‫؍‬ 200 pM and K d2 ‫؍‬ 40 nM; and HIRs-, K d1 ‫؍‬ 200 pM and K d2 ‫؍‬ 5 nM). These results extend previous observations that dimerization of the membrane-proximal ectodomain is necessary to maintain an intact highaffinity insulin-binding site.
A unique feature of the insulin receptor is that it is dimeric in the absence of ligand. Dimerization of two adjacent transmembrane domain (TMD) ␣ helices has been shown to be critical in receptor kinase activation. Moreover, previous work has suggested that the TMD is involved in stabilizing the high-affinity binding site; soluble receptors expressed after simple truncation at the ectodomain-TMD junction have reduced affinity for insulin. To further examine this issue, we have replaced the TMD and intracellular domain of the soluble human insulin receptor (HIRs) with constant domains from immunoglobulin Fc and subunits (HIRs-Fc and HIRs-). Studies of receptor biosynthesis and binding characteristics were performed following transient transfection of receptor cDNAs into human embryonal kidney 293 cells. Each hybrid receptor was initially synthesized as a single chain proreceptor, followed by cleavage into ␣-and ␤-Fc or ␤-subunits. The majority of secreted protein appeared in the cell medium as fully processed heterotetramer. Fc fragments released from HIRs-Fc by papain digestion and analyzed by nonreducing SDSpolyacrylamide gel electrophoresis were dimeric. Furthermore, dissociation constants for both chimeras were similar to those for the full-length holoreceptor (wild-type receptor, K d1 ‫؍‬ 200 pM and K d2 ‫؍‬ 2 nM; HIRsFc, K d1 ‫؍‬ 200 pM and K d2 ‫؍‬ 40 nM; and HIRs-, K d1 ‫؍‬ 200 pM and K d2 ‫؍‬ 5 nM). These results extend previous observations that dimerization of the membrane-proximal ectodomain is necessary to maintain an intact highaffinity insulin-binding site.
The metabolic effects of insulin are mediated by its binding to a specific receptor that is an integral membrane protein and a member of the tyrosine kinase family of growth factor receptors (1) (2) (3) (4) (5) . The wild-type receptor is a heterotetramer with a molecular mass of 350 -400 kDa composed of two ␣ and two ␤ subunits (6 -8) . The receptor is initially synthesized as a single chain proreceptor, which undergoes glycosylation and processing at a tetrabasic cleavage site into disulfide-linked ␣ and ␤ subunits. The ectodomain is composed of the entire ␣ subunit and 194 amino acids of the ␤ subunit (␤ o ), while the intracellular portion of the ␤ subunit contains the tyrosine kinase domain (9, 10) . Structural maturation of the insulin receptor begins in the ER 1 and involves glycosylation, acquisition of insulin binding, and dimerization, followed by proteolytic cleavage in the Golgi apparatus (11) .
A detailed three-dimensional structure of the insulin-binding site is not available, so only indirect information can be used to identify important structural features necessary for high-affinity insulin binding. Numerous residues in both the amino-and carboxyl-terminal regions of the ␣ subunit have previously been shown to be involved in insulin binding through a variety of techniques, including: 1) analysis of receptor point mutations associated with syndromes of insulin resistance (reviewed in Ref. 12); 2) photoaffinity labeling and cross-linking of insulin derivatives to the receptor, followed by identification of the bound residues (13-16); 3) site-directed mutagenesis (17, 18) ; 4) epitope-specific monoclonal antibody probes (19 -21) ; and 5) domain exchanges between insulin and insulin-like growth factor I receptors (22) (23) (24) (25) . Studies by Shoelson and others (26 -28) have demonstrated that TMD dimerization is a key step in receptor activation. However, although oligomerization of the ectodomain appears to contribute to the formation of a high-affinity binding site, the mechanism by which the insulin-bound state modulates TMD dimerization and signaling is not known.
While receptors truncated at the beginning of the transmembrane domain form dimers that bind insulin, 2 these domains alone do not appear to be able to maintain the conformation of the high-affinity insulin-binding site typical of the wild-type receptor. Findings by several laboratories that the truncated ectodomain undergoes increased degradation and has atypical binding characteristics might reflect the loss of this critical organization (29 -33) . To determine whether the TMDs stabilize the high-affinity insulin-binding site in the ectodomain, we replaced these with constant domains from several immunoglobulins. Immunoglobulin domains (both Fc and ) were selected based on their ability to form homodimers of known dimensions that might be able to support the insulin-binding 1 The abbreviations used are: ER, endoplasmic reticulum; TMD, transmembrane domain; HIR, human insulin receptor; mAb, monoclonal antibody; HIRs-Fc, soluble human insulin receptor-immunoglobulin heavy chain chimera; HIRs-, soluble human insulin receptorimmunoglobulin light chain chimera; HEK, human embryonal kidney; BES, N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis. 2 For clarity, we use the terms "dimer" and "heterotetramer" interchangeably here. The latter term indicates cleavage between the ␣ and ␤o subunits in an (␣␤o) 2 dimer.
ectodomain. Although previous studies have described the use of these domains to express soluble forms of several small cytokine receptors and CD4 molecules (34 -38) , this report is the first in which they have been used to study the functional assembly of a large multisubunit oligomeric receptor such as the HIR. Fig. 1 shows the cloning strategy used to assemble HIRs-Fc and HIRs-. The recombinant receptors were assembled in pBluescript II (Stratagene) in three steps (see Fig. 1 ). (i) Nucleotides 1670 -3006 (numbering of Ebina et al. (10) ) were amplified by polymerase chain reaction with the sense primer 5Ј-TCTTTTGACAAGATCTTGCT-GAGATGGGAG-3Ј (BglII site is underlined) and the antisense primer 5Ј-TTAAAGACTAGTAAATTTTTCGAATTTTGCAATATTTGACGGGA-C-3Ј(SpeI and SfuI sites are underlined) and subcloned into the EcoRV site of pBluescript II. (ii) Next, a fragment containing nucleotides Ϫ73 to 1670 was excised from the parent plasmid containing the full-length human insulin receptor (pSelect HIR) from the SalI (Ϫ73) to BglII (1670) sites and then subcloned into the SalI-BglII sites of pBluescript II. (iii) IgG1-Fc was amplified by polymerase chain reaction using the sense primer 5Ј-TTTACCTTCGAACACACATGCCCACCGTGCCCA-GCA-3Ј (SfuI site is underlined) and the antisense primer 5Ј-GGAC-TAGTATCGATTCATTTACCCGGAGACAGGGAGAG-3Ј for IgG-Fc (SpeI and ClaI sites are underlined), and the human IgG-6 light chain was amplified with the sense primer 5Ј-TTTACCTTCGAAAAGGGCT-GCCCCCTCGGTCACT-3Ј (SfuI site is underlined) and the antisense primer 5Ј-TTTTGGACTAGTATCGATCTATGAACATTCTGTAGGGG-CCAC-3Ј (SpeI and ClaI sites are underlined). The polymerase chain reaction-amplified fragments were digested with SfuI and SpeI and subcloned into the SfuI-SpeI sites of pBluescript II-HIRs, creating the full-length chimera. The nucleotide fragments encoding the fusion proteins were then subcloned into the SalI-ClaI sites of pCMV6b, an expression plasmid containing the major immediate-early promoter of human cytomegalovirus and the polyadenylation sequence of human growth hormone. The SalI-ClaI fragment was also subcloned by bluntend ligation into a dihydrofolate reductase expression plasmid and then cotransfected with pSV2Neo (containing the G418 antibiotic resistance cDNA) into a Chinese hamster ovary cell line lacking endogenous dihydrofolate reductase for selection in G418 (Life Technologies, Inc.) and amplification in methotrexate. Clonal cell lines were isolated and screened using horseradish peroxidase-labeled protein A (Amersham Corp.), followed by visualization with 3,3Ј-diaminobenzidine tetrahydrochloride (Sigma). Polymerase chain reaction-amplified and junction regions of the constructs were sequenced with either Sequenase (dideoxy chain termination) or SequiTherm (cycle sequencing). A cDNA encoding the human insulin holoreceptor was cloned in pCMV6b as described previously (40) .
MATERIALS AND METHODS

Miscellaneous-Bovine
Cell Transfection-HEK 293 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 100 g/ml streptomycin. 12-24 h prior to transfection, cells were seeded to 20 -40% confluency, and 1 h prior to transfection, the medium was replaced. DNA was transfected by the calcium phosphate method (41) . For each 10-cm dish, 20 g of plasmid DNA was mixed with 0.25 M CaCl 2 , followed by dropwise addition to 2 ϫ transfection buffer (final concentrations of 1.25 mM CaCl 2 , 25 mM BES, 140 mM NaCl, and 0.75 mM Na 2 HPO 4 ). The transfection mixture was incubated for 10 -20 min at room temperature, followed by addition to the cells. After incubation for 12-20 h at 37°C in 3% CO 2 , cells were washed three times with phosphate-buffered saline and incubated in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal calf serum at 37°C in 5% CO 2 .
Metabolic Labeling and Immunoprecipitation of the Fusion ProteinFollowing recovery for 24 h in growth medium, cells were washed with PBS prior to the addition of isotope for either pulse-chase or continuous labeling. For continuous labeling, cells were incubated with Dulbecco's modified Eagle's medium lacking methionine and cysteine and containing 0.1% bovine serum albumin (labeling medium). Labeling was with [ 35 S]methionine and [
35 S]cysteine (250 Ci/ml) for 18 -24 h. For pulsechase experiments, cells were first incubated for 2 h in labeling medium and then pulse-labeled for 15-60 min, washed twice in PBS, and incubated for various times in chase medium containing a 10-fold molar excess of methionine and cysteine. Additional experiments were performed in which cycloheximide was added to the medium during the chase period (10 g/ml, concentration shown to inhibit protein synthesis by Ͼ90%). For both pulse-chase and continuous labeling experiments, the medium was harvested with protease inhibitors (10 M phenylmethylsulfonyl fluoride, 5 g/ml pepstatin, and 50 g/ml leupeptin); floating cells were removed by centrifugation at 1000 rpm for 2 min; and the medium was concentrated in Centricon concentrators (YM-10, pretreated with 0.1% bovine serum albumin). The remaining cell monolayer was washed once in PBS and then lysed in buffer containing 50 mM Hepes (pH 7.8), 1% Triton X-100, 150 mM NaCl, 10 M phenylmethylsulfonyl fluoride, 50 g/ml leupeptin, and 5 g/ml pepstatin on ice.
The medium and cell lysate protein were then incubated overnight at 4°C with protein A-agarose alone or in the presence of an insulin receptor monoclonal antibody (mAb 83-14). To discern whether protein A-agarose precipitation was associated with receptor aggregation, receptors were also recovered with Sepharose-linked anti-mouse immunoglobulin (Pierce). The anti-mouse immunoglobulin was covalently linked to Sepharose using the AminoLink TM system (Pierce) according to the recommendations of the manufacturer using NaCNBH 3 for reductive amination during the coupling reaction. After incubation overnight with either protein A-agarose or mAb 83-14 and anti-IgG-Sepharose, immunoprecipitates were sedimented and washed twice in highsalt wash buffer (300 mM NaCl, 1 mM CaCl 2 , 25 mM Tris (pH 7.4), 1% Triton X-100, 10 g/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride) and once in the same buffer containing low salt (140 mM NaCl). The bound complex was then redissolved in Laemmli sample buffer containing 2% SDS, 20% (v/v) glycerol, 120 mM Tris (pH 6.8), and 0.01% bromphenol blue in the presence or absence of 100 mM dithiothreitol; heated to 95°C for 5 min; and then analyzed by 5-8% SDS-PAGE using glycine running buffer (42) . In some experiments, samples to be run under nonreducing conditions were transferred to columns made with glass wool in 200-l pipette tips and eluted in a different nonreducing sample buffer containing 100 mM Tris-HCl (pH 6.8), 2% SDS, and 9 M urea (11) .
For molecular mass determinations of the nonreduced chimeras, samples were analyzed by 3-10% linear gradient SDS-PAGE cast with a Bio-Rad Model 385 gradient gel former. The gels were fixed in 10% acetic acid and 25% isopropyl alcohol for 30 min, and protein was visualized using either a Stratagene silver stain kit or after staining with Coomassie Brilliant Blue (stained for 45 min in 0.025% Coomassie Brilliant Blue R-250, 45% methanol, and 9.2% acetic acid; destained in 7.5% acetic acid and 5% methanol for 24 h). Prior to fluorography, gels were treated with Amplify (Amersham Corp.) for 15 min. Molecular mass estimates were made by comparing the relative mobility of the receptor bands to molecular mass standards (Sigma cross-linked phosphorylase b-SDS molecular mass markers, Amersham rainbow 14 Cmethylated high molecular mass markers, and rat apoB (ϳ500 kDa; a gift of Dr. E. Fisher, Mt. Sinai School of Medicine, New York)).
Insulin Binding-Concentrated medium containing secreted protein was prepared as described above. The holoreceptor was isolated from a cell line overexpressing the membrane-bound holoreceptor (P3A) and solubilized by wheat germ affinity chromatography (16) . Competition binding with insulin was performed in buffer containing 150 mM NaCl, 20 mM Hepes (pH 7.5), 10% glycerol, 1% Triton X-100, and 10 -30 fmol of Ϫ6 M) for 20 -24 h at 4°C, in a final volume of 600 l. Bound counts were recovered by precipitation with 250 l of 54% polyethylene glycol 6000 and 150 l of 0.1% ␥-globulin, and in addition, HIRs-Fc was recovered using S. aureus protein A. Bound 125 I-insulin was counted in a ␥-counter. Specific binding was determined by subtracting counts detected in the presence of excess unlabeled insulin (Ͻ5% total counts). All binding experiments reported here were performed in duplicate on at least two separate occasions. The competition binding curves were compiled from several experiments, and each point is reported as the mean Ϯ S.D. for several experiments. Scatchard analysis was carried out as described (43) , and dissociation constants were determined using curves fit with a nonlinear least-squares algorithm to a function containing a sum of two independent binding sites using KaleideGraph TM software (Synergy Software, Reading, PA) (44) .
Papain Digestion of HIRs-Fc-Chinese hamster ovary cells expressing high levels of HIRs-Fc were incubated overnight with [ S]methionine (50 -75 Ci/ml), and the medium was harvested, concentrated (Centricon 100), and dialyzed in papain digest buffer (20 mM phosphate and 10 mM EDTA (pH 7)). Digestion was optimized using immobilized papain (Pierce) and carrier human IgG (Pierce) in the presence of 20 mM cysteine HCl for ϳ14 -18 h in a shaking 37°C water bath. Following digestion, iodoacetamide (final concentration of 75 mM) and Tris-HCl (pH 7.5; final concentration of 10 mM) were added, and the Fc fragments were recovered by protein A affinity chromatography (Pierce). Elution of the bound protein was monitored using the Bradford protein dye-binding procedure (Bio-Rad), and both unbound and protein A-bound fractions were concentrated and washed in 25 mM Tris and 192 mM glycine using Amicon concentrators (molecular mass cutoff of 10 kDa) prior to analysis of both of these fractions in the absence or presence of 5% ␤-mercaptoethanol by 5-12% SDS-PAGE. Mouse Fc fragment (Pierce) was used as a marker, and the proteins were visualized by silver staining (Amersham Corp.). The gels were then treated with Amplify, dried, and 
RESULTS
Cloning and Expression of Soluble Receptor Chimeras-
Dimerization domains of IgG are present in both heavy chain (Fc) and light chain () subunits. Both covalent and hydrophobic interchain bonds stabilize the Fc and homodimers (45, 46) . We chose the rather than a light chain because of its higher dimer stability (47) . The construction of the recombinant receptor cDNAs for expression of HIRs-Fc and HIRs-chimeras is shown in Figs. 1 and 2 . Both constructs included exon 11 of the human insulin receptor. The immunoglobulin domains were introduced in frame with the addition of serine and glutamic acid encoded by nucleotides in the SfuI site. Fig. 2 illustrates the alignment of the ectodomain with the immunoglob- 
FIG. 2. Fusion construct design.
The structures of human immunoglobulin ␥1 and are indicated. The ectodomain of the insulin receptor contains the entire ␣ subunit and the extracellular part of the ␤ subunit (929 residues). For fusion constructs, the Fc domain included the second and third constant regions including the hinge region (224 residues). The constant region was from 6 and included the carboxylterminal 103 residues. aa, amino acids. ulin domains.
Subunit Composition and Oligomerization of Soluble Chimeras-To determine the molecular mass of the secreted receptor chimeras, HEK 293 cells were transfected with HIRs-Fc and HIRs-and incubated in labeling medium overnight. Labeled protein was precipitated with either a monoclonal receptor antibody (mAb 83-14) and protein A-agarose or anti-IgGSepharose as described under "Materials and Methods." In addition, HIRs-Fc was recovered after incubation with protein A-agarose alone (Fig. 3, A, lane 3; and B, lane 3) . Mock-transfected 293 cells did not secrete protein that bound either to mAb 83-14 or to protein A (Fig. 3, A, lanes 1 and 2; and B, lanes  1 and 2) . Under reducing conditions, the ␣ subunits from secreted receptors appeared as a single band of 130 kDa, and the ␤-Fc and ␤-subunits migrated according to their predicted molecular masses (Fig. 3A, lanes 3-6) .
Estimates of the molecular masses of the receptor oligomers were made after electrophoresis of the redissolved precipitates on 3-10% linear gradient SDS-polyacrylamide gels under nonreducing conditions (Fig. 3B) . Major bands of 380 kDa (HIRsFc; Fig. 3B, lanes 3-5) and 330 kDa (HIRs-; lanes 6 and 7) were detected. These bands correspond to the predicted size of disulfide-linked heterotetramers for the respective receptors. Additional bands of variable abundance were seen at 290 kDa in several experiments, possibly representing nonreduced ␣␤-Fc and ␣␤-monomers. A similar band was observed when the wild-type receptor was analyzed by nonreducing SDS-PAGE (see Fig. 1 in Ref. 40 ). Higher molecular mass bands were visible for HIRs-Fc and probably represented aggregated protein (Fig. 3B, lanes 3 and 4) . To determine whether this aggregation occurred during incubation with protein A, HIRs-Fc was also recovered in the absence of protein A using mAb 83-14 and anti-IgG-Sepharose (Fig. 3B, lanes 4 and 5) . Although aggregated material was still present, washing through glass wool reduced the fraction of this high molecular mass material (Fig. 3B, lane 5) . In contrast, high molecular mass aggregated protein was not detected when HIRs-was recovered under similar conditions (Fig. 3B, lanes 6 and 7) .
HIRs (Fig. 4) or as a pulse-chase (Figs. 5-7) . The continuous labeling experiment revealed that HIRs-Fc was initially synthesized as a proreceptor that appeared after 15 min (Fig. 4B, lane 1) . Processing of the proreceptor into ␣-and ␤-Fc subunits was rapid (Fig. 4B, lane 1) , and by 26 h, large amounts of secreted receptor subunits had accumulated in the medium (Fig. 4A, lane 6) .
The pulse-chase experiments showed that secreted HIRs-Fc appeared in the medium by 1 h of chase and continued to accumulate in the medium between 4 and 24 h of chase (Fig.  5A, lanes 6 -8) ; very little processed receptor was retained in the cell lysate (Fig. 5B, lanes 2-8) . Cycloheximide was included during the chase to ensure that the continued accumulation of HIRs-Fc in the medium was not due to continued incorporation of incompletely removed or recycling isotopic amino acids. Preliminary experiments established that 10 g/ml cycloheximide inhibited protein synthesis by Ͼ90% (data not shown). Identical results were obtained in the presence or absence of cycloheximide, indicating that the continued accumulation of secreted HIRs-Fc between 4 and 24 h of chase was due to intracellular retention, mainly as uncleaved proreceptors. Approximately 40% of the initially synthesized proreceptor was secreted into the cell medium by 24 h. A similarly prolonged secretion phase and retention of the proreceptor were found when HIRs-Fc was transfected into Chinese hamster ovary COS-7 cells, suggesting that the delayed secretion and processing of the HIRs-Fc proreceptor were not cell type-specific (data not shown).
To rule out the possibility that the inefficient processing of HIRs-Fc was due to saturation of the convertase pathway dur- ing overexpression, HEK 293 cells were transfected with the full-length human insulin receptor, and processing was analyzed by pulse-chase (Fig. 6) . Processing of the full-length receptor was similar to that found in 3T3-L1 adipocytes (11) and in NIH 3T3 cells overexpressing the full-length receptor (48) . Labeling was for 1 h, and the appearance of the ␣ and ␤ subunits was detected 1 h after chase, with the concomitant decrease in the proreceptor band throughout the chase (Fig. 6,  lanes 1-7) . Thus, the slower kinetics of processing of HIRs-Fc were specific to this construct and were probably due to intracellular retention of misfolded chimeric molecules. We also performed pulse-chase experiments to investigate the processing of HIRs-. Fig. 7A (lanes 1-5) shows the appearance of HIRs-in medium from HEK 293 cells labeled for 2 h and chased for the indicated times. HIRs-was detected 1 h after the labeling times and continued to accumulate in the medium between 5 and 24 h of chase. Recovery of receptor from cell lysates indicated that the HIRs-proreceptor and the ␣ subunit gradually diminished over the course of the chase (Fig. 7B,  lanes 1-5) . The ␤-subunit could not be detected in cell lysates.
For both HIRs-Fc and HIRs-, the material harvested from the medium was fully processed, and no low molecular mass degradation products were detected by SDS-PAGE after 24 h of chase. The stability of the receptor was further corroborated by binding experiments, which showed retention of high-affinity binding with samples stored for Ͼ1 month at Ϫ20°C.
High-affinity Insulin Binding Is Reconstituted by HIRs-Fc and HIRs--To test whether
HIRs-Fc and HIRs-retained highaffinity insulin binding, competition assays were performed with conditioned medium harvested from transfected cells. No binding was found in media from mock transfections. Fig. 8 shows both the competition curves and Scatchard transformation for HIRsFc, HIRs-, and the holoreceptor. The IC 50 and dissociation constant data are summarized in Table I . The dissociation constants and half-maximal inhibition IC 50 values for the holoreceptor were similar to those obtained previously using similar assay conditions (Fig. 8A) (16, 40) . Binding data were compiled from at least two separate experiments, and they showed that insulin bound with high affinity to both HIRs-Fc and HIRs-(IC 50 ϭ 3 ϫ 10 Ϫ10 and 4 ϫ 10 Ϫ10 M, respectively, versus 5 ϫ 10 Ϫ10 M for the holoreceptor). Curvilinear plots were generated after Scatchard transformation for both chimeras (Fig. 8, B and C, insets) . The dissociation constants were derived from a two-site binding model (K d1 ϭ 2 ϫ 10 Ϫ10 M and K d2 ϭ 2 ϫ 10 Ϫ9 M for the holoreceptor, K d1 ϭ 2 ϫ 10 Ϫ10 M and K d2 ϭ 4 ϫ 10 Ϫ8 M for HIRs-Fc, and K d1 ϭ 2 ϫ 10 Ϫ10 M and K d2 ϭ 5 ϫ 10 Ϫ9 M for HIRs-) (44) . For binding assays with the full-length holorecep- S]cysteine (250 Ci/ml), washed with PBS, and then chased in medium containing 2 mM methionine and cysteine with 10 g/ml cycloheximide. Conditioned medium and cell lysates were collected at the indicated times. Labeled protein was recovered from the conditioned medium with protein A-agarose alone (A, lanes 1-9) and from one-fifth of the lysates with mAb 83-14 and protein A-agarose (B, lanes 1-9) . Molecular mass markers are indicated with arrowheads to the left, and receptor subunits are indicated to the right. There was no detectable HIRs-Fc proreceptor in the conditioned medium (A, lanes 1-8) . Exposure of the fluorograms was for 1 week in A and 24 h in B.
tor, wheat germ agglutinin-purified receptor was isolated from Chinese hamster ovary P3A cells as described previously (49) .
Fc Domains Are Dimeric in HIRs-Fc-To determine whether dimerization of HIRs-Fc involves only ␣ subunit interactions or whether it extends through the Fc domain, we performed papain digestion, which cleaves the receptor between the ␣-␤o and Fc domains, and analyzed the digested fragments by SDS-PAGE. Fig. 9 shows the position of Fc fragments in the presence and absence of ␤-mercaptoethanol. Fc fragment markers (Pierce) and carrier IgG digested in combination with metabolically labeled HIRs-Fc were used to identify the position of the 35 S-labeled Fc subunit released from HIRs-Fc. Analysis of the unbound wash fraction on the same gels did not reveal any monomeric 35 S-labeled Fc subunit, demonstrating that this domain exists as a dimer in HIRs-Fc (data not shown).
DISCUSSION
Oligomerization of the wild-type insulin receptor occurs in the ER and involves transition from monomer to dimer structures concomitant with the acquisition of insulin binding in the ␣ subunit (11) . Further modification occurs after translocation into the Golgi apparatus, where proteolytic cleavage between the ␣ and ␤ subunits corresponds to the appearance of a slower migrating heterotetramer that is transferred to the plasma membrane. The role of receptor assembly in production of a high-affinity binding site for insulin is incompletely understood. Acquisition of insulin binding activity in the ER precedes complete dimerization, and both in vitro and in vivo crosslinking of insulin to the wild-type receptor have indicated that insulin contacts a single ␣ subunit (50, 51) . However, purified ␣␤ receptor monomers display lower affinity for insulin than the intact (␣␤) 2 receptor dimer (52, 53) , suggesting that formation of the high-affinity insulin-binding site requires complete oligomerization. Evidence that steric interactions between the two ␣␤ receptor halves in the dimer are necessary to produce high-affinity binding comes from the analysis of hybrid receptors composed of one ␣␤ receptor-half containing a point mutation in the ␣ subunit 3 and one wild-type ␣␤ receptor-half (54).
Hybridization of the mutant half-receptor with one wild-type half-receptor was sufficient to restore high-affinity insulin binding to the receptor. However, cross-linking of insulin to the hybrid receptor showed that insulin bound to the wild-type ␣ subunit only, indicating that the mutant half-receptor contributed the appropriate steric interactions to form a high-affinity binding site. Because these hybrid receptors contained the entire ectodomain, the TMD, and the intracellular tyrosine kinase domain, the specific domains necessary to support the high-affinity site were not localized (54) . Moreover, it is known that regions distant from the ␣ subunit support the binding site since ␣ domain dimerization requires the presence of the ␤o subunit (33) . In addition to the role of receptor oligomerization in the formation of a high-affinity insulin-binding site, oligomerization was shown to be critical in activation of the intracellular tyrosine kinase because substitution of the insulin receptor TMD with the dimeric neu/erbB2 TMD resulted in constitutive activation of the intracellular kinase (27, 28) . We propose a model that further localizes critical residues necessary to stabilize the ectodomain dimer and extends observations that receptor oligomerization contributes at multiple levels to receptor function. Fig. 10 depicts our model in a highly schematic form, illustrating the concepts that 1) two ␣ subunits are necessary for formation of the high-affinity binding site; 2) dimerization of the ␣ subunits is stabilized in the wild-type receptor by the ␤ o subunit, which is in turn stabilized by the TMD; and 3) reproducing the high-affinity binding site in vitro 3 The mutation was identified in a patient with insulin-resistant diabetes who was homozygous for the S323L mutant allele (54). is achieved by anchoring the ␤ o subunit through fusion to dimerization domains of immunoglobulin Fc. This model is consistent with our data characterizing HIRs-Fc and HIRs-.
Assembly of the soluble receptors into oligomers of the predicted size of tetramers and the presence of high-affinity insulin binding with curvilinear Scatchard plots suggest that structural features of the native transmembrane receptor are retained. Papain digestion of HIRs-Fc showed that the Fc domain exists predominantly as the dimer, indicating that the most carboxyl-terminal residues of the ␤ o subunit, which are fused to this domain, maintain close association. However, some degree of aggregation of secreted HIRs-Fc was evident on nonreducing SDS-PAGE. Because the abundance of the aggregated receptor varied between different experiments, it is possible that factors involved in preparation of the samples for SDS-PAGE, such as protein concentration, and length of time in storage affect the relative proportion of the aggregated species (55) . On the other hand, it is possible that during biosynthesis, the Fc domain of the chimeric proreceptor monomer folds independently and rapidly, forming disulfide links with nearby Fc subunits from other proreceptor dimers and/or monomers. A similar phenomenon, termed domain swapping, has been demonstrated to give rise to dimeric forms of diphtheria toxin (56) . Such swapping of Fc domains might contribute to intracellular retention of this insulin receptor fusion.
Using pulse-chase labeling, we have shown that HIRs-Fc and HIRs-were initially synthesized as single chain proreceptors. Cleavage into ␣-and ␤-Fc subunits occurred intracellularly and could be detected in lysates as early as after 15 min of pulse labeling, increasing gradually up to 24 h of chase. HIRs-Fc was secreted only after complete cleavage of the proreceptor. In contrast, the truncated receptor produced in baculovirus-transfected Sf9 cells was heterogeneous, with culture medium containing both cleaved and uncleaved receptor forms (30, 31) . Furthermore, HIRs expressed in both NIH 3T3 cells and Sf9 cells was degraded during chase times between 6 and 24 h after 
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labeling (29, 31) . As shown in Fig. 5A , culture medium from 293 cells transfected with HIRs-Fc contained a homogeneous population of ␣-and ␤-Fc subunits as indicated by the low background when the receptor was partially purified by protein A-agarose binding. The lack of significant intracellular accumulation of ␣-and ␤-Fc subunits indicates that the cleaved receptor was rapidly secreted after cleavage. This suggests that the rate-limiting step in secretion occurred prior to cleavage. The possibility was considered that the accumulation of the HIRs-Fc proreceptor might be due to saturation of the endogenous convertase (furin) responsible for cleavage of the proreceptor (57) . However, the demonstration of normal processing of both the wild-type receptor (Fig. 6 ) and HIRs- (Fig. 7) indicates that sufficient capacity for processing these overexpressed receptors exists in the HEK 293 cells. Also, mutation of cleavage sites to abrogate cleavage does not result in retention of the proreceptor (58) . Furthermore, we found that the HIRs-Fc proreceptor accumulated in COS-7 cells transfected under identical conditions (data not shown).
It is thus more likely that the accumulation of the HIRs-Fc proreceptor involved misfolding of the proreceptor. Pulse-chase studies of insulin receptor processing in 3T3 adipocytes by Olson et al. (11) showed that folding of the receptor, measured by disulfide bond formation and the formation of (␣␤) 2 receptor homodimers, precedes proteolytic cleavage of the proreceptor into ␣ 2 ␤ 2 heterotetramers. In addition, impairment of the carbohydrate maturation of the proreceptor was previously shown to delay cleavage and resulted in the accumulation of intracellular proreceptor (59) . It is now well established that the folding and assembly of oligomeric proteins are modulated by the interaction of protein chaperones that are involved in the recognition of both partially folded nascent proteins and misfolded proteins (60) . These chaperones normally associate in sequential interactions during the assembly of oligomeric proteins (61) . Although only limited information is available regarding the specific chaperones involved in insulin receptor assembly, Accili et al. (62) found that the association between Binding Protein Glucose-Regulated Protein 78 (BiP/GRP78) and the insulin receptor was prolonged when receptors containing a point mutation in the amino terminus of the ␣ subunit were compared with wild-type receptors. It is likely that other chaperones are involved in folding of the wild-type receptor, acting in concert with BiP to attain the correct receptor structure (60, 61, 63) . The accumulation of misfolded insulin receptors might involve a number of processes, including point mutations, disordered disulfide bond formation, domain swapping, impaired carbohydrate maturation, or a disequilibrium of the normal association with chaperones. An intriguing possibility is that the coexpression of enzymes such as protein-disulfide isomerase or manipulating other steps in the folding pathway might drive more of the HIRs-Fc proreceptor into its mature form (64 -67) .
One feature of insulin binding activity by the membranebound full-length receptor is that Scatchard analysis yields a ]methionine (50 -75 Ci/ml each), and the secreted receptor was prepared for papain digestion as described under "Materials and Methods." The digests were subjected to protein A chromatography, followed by analysis of the bound and unbound fractions by 5/12% SDS-PAGE (stacking/running gel) in the absence (lane 1) or presence (lane 2) of 5% ␤-mercaptoethanol (ME). The proteins were visualized by silver staining and then treated with Amplify, dried, and exposed to Kodak X-Omat film. Mouse Fc fragment was used as a marker and is indicated with arrows. The position of the [ curvilinear rather than a linear plot. Because the slope of the Scatchard curve is proportional to the inverse of the dissociation constant, a linear curve with a single dissociation constant might represent binding to one class of binding sites, whereas a concavely curvilinear plot usually is believed to reflect the presence of multiple binding sites. De Meyts has presented extensive evidence (reviewed in Ref. 68) to suggest that the complex kinetics of insulin binding to the receptor reflect the presence of negative cooperativity between separate insulinbinding sites. According to the model of De Meyts, a single molecule of insulin binds to two distinct sites on opposite ␣ subunit halves of the (␣␤) 2 receptor dimer. Simple binding kinetics have been found with truncated secreted receptors in both mammalian and insect expression systems, suggesting a loss of the native binding properties of the wild-type receptor (30 -32) . In contrast, Scatchard analysis of HIRs-Fc and HIRsbinding was curvilinear, and apparent dissociation constants were similar to those of the holoreceptor (Table I) . Dimerization domains anchor the ectodomain while permitting enough flexibility for subtle structural changes that occur with ligand binding and form the basis of complex binding kinetics.
We conclude that the fusion of immunoglobulin heavy and light chain domains to the insulin receptor ectodomain demonstrates a function of residues in the most membrane-proximal region in supporting the high-affinity insulin-binding site. Chimeric receptors provide a novel in vitro system for further studies of the structural and mechanistic effects of insulin binding to the receptor. Elucidation of the basis for the delayed folding of HIRs-Fc might aid in defining the pathway of assembly of the chimeric as well as wild-type receptors. For HIR-Fc, protein A affinity could be advantageous in the development of a receptor-based assay for measurement of insulin bioactivity. We also are currently exploring the possibility that overexpression of these chimeras could provide material for detailed structural analysis of the insulin receptor-binding domain.
